Document is current
Any future updates will be listed below
-
Authors
Alvarez-Rodrigo, Ines https://orcid.org/0000-0003-2181-5535
Willnow, David https://orcid.org/0000-0001-6220-3901
Alexandre, Cyrille
Lebarbenchon, Claire https://orcid.org/0009-0004-3827-8179
Borg, Annabel https://orcid.org/0000-0003-2873-7226
Findlay, Heather
Hoad Leftley, Maya https://orcid.org/0009-0004-9724-944X
Arahouan, Ikram
Zhao, Yuguang
di Pietro, Florencia
Kjaer, Svend
Booth, Paula
Bauer, Reinhard
Jones, E Yvonne https://orcid.org/0000-0002-3834-1893
Bellaïche, Yohanns https://orcid.org/0000-0003-1686-2943
Vincent, Jean-Paul https://orcid.org/0000-0003-2305-5744
-
Funding
Funding for this research was provided by:
Wellcome Trust (223133/Z/21/Z)
Wellcome Trust (214259/Z/18/)
Francis Crick Institute (FC001204)
Institut Curie (UMR3215-U934)
CNRS | Institut des sciences biologiques (UMR3215)
Institut National de la Santé et de la Recherche Médicale (U934)
Agence Nationale de la Recherche (TiMecaDiv 20CE13000801)
Deutsche Forschungsgemeinschaft (SFB 645)
- License Information
-
More Information
Article History
Received: 16 April 2026
Revised: 10 July 2026
Accepted: 15 July 2026
First Online: 3 August 2026
Disclosure and competing interests statement
: IA is currently employed as a Regulatory Affairs Manager at a pharmaceutical company. However, this employment is unrelated to the work presented in the paper, and there is no conflict of interest.
